tiprankstipranks
Trending News
More News >
Angelalign Technology Inc. (HK:6699)
:6699
Hong Kong Market
Advertisement

Angelalign Technology Inc. (6699) AI Stock Analysis

Compare
7 Followers

Top Page

HK:6699

Angelalign Technology Inc.

(6699)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
HK$74.00
▲(9.96% Upside)
Angelalign Technology Inc. scores moderately due to its stable financial performance and positive technical indicators. However, the high P/E ratio suggests overvaluation, which impacts the overall attractiveness of the stock. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Strong Revenue Growth
The company's consistent revenue growth indicates a positive market position and demand for its products, supporting long-term business expansion.
Low Leverage
Low leverage enhances financial stability, reducing risk and providing flexibility for future investments and growth opportunities.
Strong Cash Generation
Strong cash generation capabilities enable the company to reinvest in growth initiatives and maintain financial health, supporting sustainable operations.
Negative Factors
Low Net Profit Margin
A low net profit margin suggests limited profitability, which could impact the company's ability to generate sufficient returns and reinvest in growth.
Operational Inefficiencies
Negative EBIT margin indicates operational challenges, which may hinder profitability and require strategic adjustments to improve efficiency.
Cash Flow Management Issues
Challenges in converting income into cash could affect liquidity and the ability to fund operations, necessitating improved cash flow management.

Angelalign Technology Inc. (6699) vs. iShares MSCI Hong Kong ETF (EWH)

Angelalign Technology Inc. Business Overview & Revenue Model

Company DescriptionAngelalign Technology Inc. (6699) is a leading provider of clear aligner solutions in the dental sector, specializing in innovative orthodontic products designed to improve the alignment of teeth. The company operates primarily in the dental technology industry, offering a comprehensive range of services that include the design, manufacturing, and distribution of customized clear aligners. Through its advanced digital platform, Angelalign facilitates seamless interactions between dental professionals and patients, ensuring effective treatment outcomes.
How the Company Makes MoneyAngelalign Technology Inc. generates revenue primarily through the sale of its clear aligner products to dental practitioners and clinics. The company employs a business model that includes direct sales of aligners, as well as associated services such as treatment planning and consultation. Additional revenue streams may include partnerships with dental practices and orthodontic professionals, licensing agreements for proprietary technology, and potential expansions into related dental products or services. The company's advanced digital platform is also a significant factor in driving sales, as it enhances the customer experience and streamlines the treatment process, fostering customer loyalty and repeat business.

Angelalign Technology Inc. Financial Statement Overview

Summary
Angelalign Technology Inc. demonstrates a stable financial position with strong revenue growth and low leverage. However, profitability margins and cash flow conversion ratios indicate areas for improvement. The company is well-positioned in terms of financial stability, but enhancing operational efficiency and cash flow management could further strengthen its financial health.
Income Statement
65
Positive
Angelalign Technology Inc. shows a moderate revenue growth rate of 7.08% TTM, indicating a positive trajectory. The gross profit margin remains strong at 62.59%, reflecting efficient cost management. However, the net profit margin is relatively low at 4.51%, suggesting room for improvement in profitability. The EBIT margin is negative, highlighting potential operational inefficiencies.
Balance Sheet
75
Positive
The company maintains a very low debt-to-equity ratio of 0.004, indicating strong financial stability and low leverage risk. The return on equity is modest at 4.98%, suggesting moderate efficiency in generating returns from equity. The equity ratio is healthy, showcasing a solid capital structure.
Cash Flow
70
Positive
Angelalign Technology Inc. exhibits a significant free cash flow growth rate of 264.85% TTM, indicating strong cash generation capabilities. However, the operating cash flow to net income ratio is relatively low at 0.13, suggesting potential challenges in converting income into cash. The negative free cash flow to net income ratio highlights potential cash flow management issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.23B1.96B1.48B1.27B1.27B816.53M
Gross Profit1.39B1.23B920.71M785.69M826.65M575.05M
EBITDA177.56M77.34M154.39M318.65M372.47M224.51M
Net Income169.84M88.42M53.48M213.78M285.85M150.69M
Balance Sheet
Total Assets5.59B4.95B4.76B4.49B4.14B1.21B
Cash, Cash Equivalents and Short-Term Investments3.49B436.83M3.44B3.65B3.63B877.58M
Total Debt651.66M14.48M65.28M28.20M30.29M14.17M
Total Liabilities2.14B1.44B1.35B884.01M826.11M712.47M
Stockholders Equity3.41B3.46B3.34B3.61B3.32B501.70M
Cash Flow
Free Cash Flow166.46M-76.78M51.28M51.48M241.95M366.61M
Operating Cash Flow376.79M123.48M165.87M146.87M441.71M408.28M
Investing Cash Flow-439.06M-138.82M-981.71M-159.77M-182.05M-7.28M
Financing Cash Flow-34.78M-28.46M-187.06M-193.61M2.52B-23.33M

Angelalign Technology Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price67.30
Price Trends
50DMA
65.92
Positive
100DMA
62.50
Positive
200DMA
59.12
Positive
Market Momentum
MACD
0.89
Negative
RSI
58.57
Neutral
STOCH
70.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6699, the sentiment is Positive. The current price of 67.3 is above the 20-day moving average (MA) of 63.73, above the 50-day MA of 65.92, and above the 200-day MA of 59.12, indicating a bullish trend. The MACD of 0.89 indicates Negative momentum. The RSI at 58.57 is Neutral, neither overbought nor oversold. The STOCH value of 70.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6699.

Angelalign Technology Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
€10.68B17.5823.40%2.89%6.51%4.85%
74
Outperform
€5.18B10.9217.42%3.73%6.87%18.37%
74
Outperform
HK$22.89B39.6124.57%0.68%13.58%24.59%
70
Neutral
HK$5.45B26.3510.31%0.98%14.06%3.02%
68
Neutral
HK$24.42B11.598.34%4.44%0.74%2.13%
63
Neutral
HK$11.48B240.00
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6699
Angelalign Technology Inc.
67.30
2.66
4.12%
HK:1066
Shandong Weigao Group Medical Polymer Co
5.42
0.70
14.81%
HK:9997
Kangji Medical Holdings Limited
9.05
3.23
55.58%
HK:3600
Modern Dental Group Limited
5.34
1.78
50.17%
HK:1501
Shanghai Kindly Medical Instruments Co., Ltd. Class H
30.50
2.50
8.93%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
49.68
35.50
250.35%

Angelalign Technology Inc. Corporate Events

Angelalign Technology Inc. Announces Board Composition and Roles
Nov 2, 2025

Angelalign Technology Inc. has announced the composition of its board of directors and the roles within its various committees. This announcement highlights the company’s commitment to structured governance and strategic leadership, which may influence its operational efficiency and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$67.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Appoints New Chief Strategy Officer
Oct 24, 2025

Angelalign Technology Inc. has announced the creation of a new senior management position, Chief Strategy Officer, to enhance its strategic planning and innovation efforts. Mr. Song Xin, previously the Chief Operating Officer, has been appointed to this role, which is expected to help the company leverage its success in China globally and drive future innovation.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$63.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Updates Investment Details in Shanghai Maxflex
Sep 2, 2025

Angelalign Technology Inc. announced a supplemental update regarding its investment in a connected entity, Shanghai Maxflex. The announcement clarifies the involvement of other independent third-party shareholders in Shanghai Maxflex, alongside the Group and CareCapital Group, the controlling shareholder of Angelalign. This update does not alter the previously disclosed information and maintains the validity of the original announcement, potentially impacting the company’s strategic positioning and stakeholder relationships.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$86.47 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Reports Strong Growth in H1 2025
Aug 25, 2025

Angelalign Technology Inc. reported a significant increase in revenue and profits for the first half of 2025, with revenue rising by 33.1% to USD161.4 million and net profit surging by 583.6% to USD14.2 million. The growth was driven by strategic pricing adjustments in mainland China and a substantial increase in shipments to global markets, despite a segment operating loss outside of mainland China. The company announced a special interim dividend, reflecting its strong financial performance and commitment to shareholder returns.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$72.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Announces Special Interim Dividend
Aug 25, 2025

Angelalign Technology Inc. has announced a special interim dividend of HKD 0.46 per share for the six-month period ending June 30, 2025. This announcement reflects the company’s robust financial performance and commitment to returning value to its shareholders, potentially enhancing its market position and stakeholder confidence.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$72.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Expands Stake in Shanghai Maxflex
Aug 25, 2025

Angelalign Technology Inc., through its wholly-owned subsidiary Wuxi EA, has entered into an investment agreement with Shanghai Maxflex, acquiring a 5% stake for RMB10 million. This transaction, which increases Angelalign’s equity interest in Shanghai Maxflex to approximately 9.7%, is classified as a connected transaction under Hong Kong’s Listing Rules due to the involvement of CareCapital Group, the controlling shareholder. The investment is subject to certain conditions, including necessary approvals and the absence of material adverse effects.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$72.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Updates Post-IPO Schemes for Enhanced Administration
Aug 25, 2025

Angelalign Technology Inc. announced amendments to its Post-IPO RSU and Share Option Schemes to streamline administration and ensure compliance with applicable laws. These changes, considered procedural and housekeeping in nature, are intended to facilitate the schemes’ implementation, aligning with the interests of the Group and its shareholders.

The most recent analyst rating on (HK:6699) stock is a Hold with a HK$72.00 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Technology Inc. Schedules Board Meeting to Review Interim Results
Aug 7, 2025

Angelalign Technology Inc. has announced a board meeting scheduled for August 25, 2025, to discuss and approve the unaudited interim results for the first half of the year ending June 30, 2025. The meeting will also consider the potential payment of an interim dividend, which could impact stakeholders and reflect the company’s financial health.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Angelalign Projects Over 500% Profit Increase for H1 2025
Aug 5, 2025

Angelalign Technology Inc. has announced a significant increase in its projected net profit for the first half of 2025, expecting a rise of approximately 538.1% to 604.8% compared to the same period in 2024. This growth is attributed to strategic pricing adjustments in China, a delay in setting up non-China manufacturing facilities, and a low profit base from the previous year. The company is also focusing on expanding its global presence and supply chain resilience, despite regulatory uncertainties in China and potential tariff challenges in Brazil.

The most recent analyst rating on (HK:6699) stock is a Buy with a HK$69.55 price target. To see the full list of analyst forecasts on Angelalign Technology Inc. stock, see the HK:6699 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 04, 2025